Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry
Shiyou Zhu(Peking University), Wensheng Wei(Peking University), Xia Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Feng Tian(Sun Yat-sen University), Shuo Du(China National Petroleum Corporation (China)), Xuran Niu(Peking University), Junyu Xiao(Peking University), Qiheng Li(Tsinghua University), Chunhui Wang(Zhejiang Sci-Tech University), Ying Liu(Central South University), Jianwei Wang(Zhejiang Cancer Hospital), Ang Chen(Huazhong University of Science and Technology), Zhiying Zhang(Inner Mongolia Medical University), Zhiheng Liu(Peking University), Shihua Chen(Peking University), Xiaojing Dong(Chinese Academy of Medical Sciences & Peking Union Medical College), Yiyuan Xu(Peking University), Qian Pan(Peking University), Zhuo Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 76
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study
|Chinese Medical Journal|2020|1.4k